Literature DB >> 30109834

Assessing the severity of influenza: a role for longitudinal telephone surveys?

R G Pebody1, N L Boddington1, H K Green1, S Bolotin1, A Charlett1, J M Watson2.   

Abstract

During the 2009 influenza pandemic, a rapid assessment of disease severity was a challenge as a significant proportion of cases did not seek medical care; care-seeking behaviour changed and the proportion asymptomatic was unknown. A random-digit-dialling telephone survey was undertaken during the 2011/12 winter season in England and Wales to address the feasibility of answering these questions. A proportional quota sampling strategy was employed based on gender, age group, geographical location, employment status and level of education. Households were recruited pre-season and re-contacted immediately following peak seasonal influenza activity. The pre-peak survey was undertaken in October 2011 with 1061 individuals recruited and the post-peak telephone survey in March 2012. Eight hundred and thirty-four of the 1061 (78.6%) participants were successfully re-contacted. Their demographic characteristics compared well to national census data. In total, 8.4% of participants self-reported an influenza-like illness (ILI) in the previous 2 weeks, with 3.2% conforming to the World Health Organization (WHO) ILI case definition. In total, 29.6% of the cases reported consulting their general practitioner. 54.1% of the 1061 participants agreed to be re-contacted about providing biological samples. A population-based cohort was successfully recruited and followed up. Longitudinal survey methodology provides a practical tool to assess disease severity during future pandemics.

Entities:  

Keywords:  Epidemiology; pneumococci; vaccine policy development; vaccine preventable diseases; vaccines

Mesh:

Year:  2018        PMID: 30109834      PMCID: PMC6453002          DOI: 10.1017/S0950268818002261

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   4.434


  18 in total

1.  Collection of routine national seasonal influenza vaccine coverage data from GP practices in England using a web-based collection system.

Authors:  Peter Gates; Karen Noakes; Fateha Begum; Richard Pebody; David Salisbury
Journal:  Vaccine       Date:  2009-09-09       Impact factor: 3.641

2.  Assessing the severity of the novel influenza A/H1N1 pandemic.

Authors:  Tini Garske; Judith Legrand; Christl A Donnelly; Helen Ward; Simon Cauchemez; Christophe Fraser; Neil M Ferguson; Azra C Ghani
Journal:  BMJ       Date:  2009-07-14

3.  Experience and lessons from surveillance and studies of the 2009 pandemic in Europe.

Authors:  A Nicoll; A Ammon; A Amato Gauci; A Amato; B Ciancio; P Zucs; I Devaux; F Plata; A Mazick; K Mølbak; T Asikainen; P Kramarz
Journal:  Public Health       Date:  2010-01       Impact factor: 2.427

4.  Assessment of baseline age-specific antibody prevalence and incidence of infection to novel influenza A/H1N1 2009.

Authors:  P Hardelid; N J Andrews; K Hoschler; E Stanford; M Baguelin; P A Waight; M Zambon; E Miller
Journal:  Health Technol Assess       Date:  2010-12       Impact factor: 4.014

5.  Pneumonia hospitalizations among young children before and after introduction of pneumococcal conjugate vaccine--United States, 1997-2006.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2009-01-16       Impact factor: 17.586

6.  Emergence of a novel swine-origin influenza A (H1N1) virus in humans.

Authors:  Fatimah S Dawood; Seema Jain; Lyn Finelli; Michael W Shaw; Stephen Lindstrom; Rebecca J Garten; Larisa V Gubareva; Xiyan Xu; Carolyn B Bridges; Timothy M Uyeki
Journal:  N Engl J Med       Date:  2009-05-07       Impact factor: 91.245

7.  Influenza vaccination coverage against seasonal and pandemic influenza and their determinants in France: a cross-sectional survey.

Authors:  Sophie Vaux; Dieter Van Cauteren; Jean-Paul Guthmann; Yann Le Strat; Véronique Vaillant; Henriette de Valk; Daniel Lévy-Bruhl
Journal:  BMC Public Health       Date:  2011-01-12       Impact factor: 3.295

8.  Influenza serological studies to inform public health action: best practices to optimise timing, quality and reporting.

Authors:  Karen L Laurie; Patricia Huston; Steven Riley; Jacqueline M Katz; Donald J Willison; John S Tam; Anthony W Mounts; Katja Hoschler; Elizabeth Miller; Kaat Vandemaele; Eeva Broberg; Maria D Van Kerkhove; Angus Nicoll
Journal:  Influenza Other Respir Viruses       Date:  2012-04-30       Impact factor: 4.380

9.  The effectiveness of U.S. public health surveillance systems for situational awareness during the 2009 H1N1 pandemic: a retrospective analysis.

Authors:  Michael A Stoto
Journal:  PLoS One       Date:  2012-08-22       Impact factor: 3.240

10.  Barriers to pandemic influenza vaccination and uptake of seasonal influenza vaccine in the post-pandemic season in Germany.

Authors:  Merle M Böhmer; Dietmar Walter; Gerhard Falkenhorst; Stephan Müters; Gérard Krause; Ole Wichmann
Journal:  BMC Public Health       Date:  2012-10-31       Impact factor: 3.295

View more
  2 in total

1.  Real-time estimation of the influenza-associated excess mortality in Hong Kong.

Authors:  Jessica Y Wong; Edward Goldstein; Vicky J Fang; Benjamin J Cowling; Peng Wu
Journal:  Epidemiol Infect       Date:  2019-01       Impact factor: 2.451

2.  Active surveillance documents rates of clinical care seeking due to respiratory illness.

Authors:  Marta Galanti; Devon Comito; Chanel Ligon; Benjamin Lane; Nelsa Matienzo; Sadiat Ibrahim; Atinuke Shittu; Eudosie Tagne; Ruthie Birger; Minhaz Ud-Dean; Ioan Filip; Haruka Morita; Raul Rabadan; Simon Anthony; Greg A Freyer; Peter Dayan; Bo Shopsin; Jeffrey Shaman
Journal:  Influenza Other Respir Viruses       Date:  2020-05-16       Impact factor: 4.380

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.